Activity Description
Community hematology/oncology practices play a critical role to expand patient access to hematopoietic cell transplantation (HCT) and improve patient outcomes.
This self-guided online training course series consists of five courses designed to present the current state of the science for Hematopoietic Cell Transplantation (HCT) by following the evolution of HCT over time. The series is broken down into major misperceptions or myths about HCT and cellular therapy that are not supported by current research and clinical practice.
This is Part 2 in a 5-part series, covering advances that have expanded eligibility for HCT and considerations for who is a candidate.
Speakers
Sanjeet Dadwal, MD
City of Hope
Duarte, CA, USA
Sanjeet Dadwal, MD, has a financial interest/relationship or affiliation in the form of:
Advisory Board/Consultant: Allovir, Ansun Biopharma, Aseptiscope, Inc., Karius, Merck
Speakers’ Bureau: Karius
Research Grant: Allovir, Ansun Biopharma, Karius
Other: has stocks in AseptiScope, Inc., Cidara, Matinas Biopharma
The following relationships have ended within the last 24 months:
Speakers’ Bureau: Astellas, Merck, Takeda
Annie Im, MD, FASCO
UPMC Hillman Cancer Center/University of Pittsburgh
Pittsburgh, PA, USA
Annie Im, MD, FASCO, has a financial interest/relationship or affiliation in the form of:
Research Grant: Incyte
The following relationships have ended within the last 24 months:
Advisory Board/Consultant: AbbVie, Incyte, Sanofi
Accreditation and Disclosure Information
Target Audience
This activity is intended for community hematology/oncology practitioners including physicians, APPs, and nurses involved in the diagnosis of HCT-indicated diseases and essential for referral to a transplant center for HCT and cell therapy consultation.
Educational Objectives
After completing this activity, the participant should be better able to:
- Implement strategies to overcome misperceptions about HCT patient and disease-related eligibility.
- Review conditioning advances making chronological age is no longer a barrier to HCT.
- Describe how transplant teams assess and address comorbidities to improve fitness for transplant.
- Examine the role of measurable residual disease or MRD in HCT.
- Discuss the future of CAR-T therapy and HCT.
Program Agenda
- Dispelling Misperceptions, Part 2: Candidates for Transplant
- Reduced-Intensity Conditioning and Age Considerations
- Assessing and Addressing Comorbidities
- MRD and HCT
- CAR-T and HCT
Accreditation, Support and Credit
In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc., and NMDP. Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Medical Learning Institute, Inc. (MLI) designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Professional Development
Successful completion of this nursing continuing professional development activity will be awarded 0.75 contact hour and 0.3 contact hour in the area of pharmacology.
Interprofessional Continuing Education (IPCE) Statement
This activity was planned by and for the healthcare team, and learners will receive 0.75 Interprofessional Continuing Education (IPCE) credit for learning and change.
Support Statement
There is no commercial support associated with this CE activity.
Disclosure & Conflict of Interest Policy
Medical Learning Institute, Inc. and NMDP are committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, MLI requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to MLI policy. These disclosures will be provided to learners prior to the start of the CE activity.
Faculty Disclosures
Planner
Sanjeet Dadwal, MD
City of Hope Duarte, CA, USA
Sanjeet Dadwal, MD, has a financial interest/relationship or affiliation in the form of:
Advisory Board/Consultant: Allovir, Ansun Biopharma, Aseptiscope, Inc., Karius, Merck
Speakers’ Bureau: Karius
Research Grant: Allovir, Ansun Biopharma, Karius
Other: has stocks in AseptiScope, Inc., Cidara, Matinas Biopharma
The following relationships have ended within the last 24 months:
Speakers’ Bureau: Astellas, Merck, Takeda
Planner
Annie Im, MD, FASCO
UPMC Hillman Cancer Center/University of Pittsburgh
Pittsburgh, PA, USA
Annie Im, MD, FASCO, has a financial interest/relationship or affiliation in the form of:
Research Grant: Incyte
The following relationships have ended within the last 24 months:
Advisory Board/Consultant: AbbVie, Incyte, Sanofi
All of the relevant financial relationships of individuals for this activity have been mitigated.
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from Medical Learning Institute, Inc., the accredited provider, and NMDP, the joint provider, do not have any relevant financial relationships to disclose with ineligible companies unless listed below.
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Method of Participation
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. A passing score of 70% or higher is needed to obtain credit. You will receive your certificate from Medical Learning Institute, Inc.
For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
If you have questions regarding your certificate, please contact Mary Vu via email at mvu@mlieducation.org
About this Activity
Medical Learning Institute, Inc. and NMDP are responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions.
The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of Medical Learning Institute, Inc. or any of its partners, providers, and/or supporters.
Copyright © 2024 Medical Learning Institute, Inc. All Rights Reserved.
Resources
Download the course resources from within the presentation lesson.